P LAMBIN - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

P LAMBIN

Showing results (111-120 of 215) with videos related to

Pageof 22

Sort By:

Gene Therapy|August 18, 2001

Radio-responsive recA promoter significantly increases TNFalpha production in recombinant clostridia after 2 Gy irradiationS Nuyts, L Van Mellaert, J Theys, et al.

Journal of Immunological Methods|September 27, 1993

Purification of human IgG4 subclass with allergen-specific blocking activityP Lambin, A Bouzoumou, M Murrieta, et al.

Bulletin Du Cancer|July 1, 1994

[Method for evaluating long term complications. A study from a phase III trial comparing two low dose rates in gynecologic brachytherapy]R Lancar, A Kramar, C Haie-Meder, et al.

International Journal of Radiation Oncology, Biology, Physics|July 30, 1994

Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinomaC Haie-Meder, A Kramar, P Lambin, et al.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|December 18, 2014

Current preclinical and clinical applications of hypoxia PET imaging using 2-nitroimidazolesS G Peeters, C M Zegers, A Yaromina, et al.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1993

Influence of cisplatinum on intestinal tolerance to photon and neutron irradiation in miceP Lambin, P Scalliet, B Coster, et al.

Journal of Acquired Immune Deficiency Syndromes|January 1, 1989

Clinical and biological features in the 12 months preceding onset of AIDS in HIV-infected subjectsJ J Lefrere, A M Courouce, P Lambin, et al.

Blood|May 1, 1987

Human monoclonal antibody against Rh(D) antigen: partial characterization of the Rh(D) polypeptide from human erythrocytesC Bloy, D Blanchard, P Lambin, et al.

AIDS (London, England)|April 1, 1991

Frequency and prognostic importance of thrombocytopenia in symptom-free HIV-infected individuals: a 5-year prospective studyJ Y Peltier, P Lambin, C Doinel, et al.

The Cochrane Database of Systematic Reviews|January 28, 2005

Early versus late chest radiotherapy for limited stage small cell lung cancerM C G Pijls-Johannesma, D De Ruysscher, P Lambin, et al.

Pageof 22